These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6859841)

  • 1. Comparative in vitro activity of semisynthetic penicillins against Proteeae.
    Hawkey PM; Pedler SJ; Turner A
    Antimicrob Agents Chemother; 1983 Apr; 23(4):619-21. PubMed ID: 6859841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences among Providencia species in their in vitro susceptibilities to five antibiotics.
    Penner JL; Preston MA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):868-71. PubMed ID: 7235674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.
    Hawkey PM; Hawkey CA
    J Antimicrob Chemother; 1984 Nov; 14(5):485-9. PubMed ID: 6511707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1991 Feb; 44(2):140-9. PubMed ID: 2041155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial susceptibility patterns of the Proteeae in Japan, 1989].
    Igari J; Hayashi Y; Shitara S; Shitara M; Yoshimoto K; Ohmizu Y; Umetsu M; Sasaki J; Kawana R; Yoshida T
    Jpn J Antibiot; 1993 Apr; 46(4):285-94. PubMed ID: 8515560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.
    Penner JL; Preston MA; Hennessy JN; Barton LJ; Goodbody MM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):218-21. PubMed ID: 6765415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of antibiogram, antibiotic resistance genes and class 1 and 2 integrons in tribe Proteeae with IMP27 gene for the first time in Providencia sp. isolated from pet turtles.
    Pathirana HNKS; Shin GW; Wimalasena SHMP; Hossain S; De Silva BCJ; Dahanayake PS; Heo GJ
    Lett Appl Microbiol; 2018 Dec; 67(6):620-627. PubMed ID: 30238643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speciation, serotyping, antimicrobial sensitivity and plasmid content of Proteeae from the environment of calf-rearing units in South West England.
    Hawkey PM; Penner JL; Linton AH; Hawkey CA; Crisp LJ; Hinton M
    J Hyg (Lond); 1986 Dec; 97(3):405-17. PubMed ID: 3540110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains.
    Stock I; Wiedemann B
    J Med Microbiol; 1998 Jul; 47(7):629-42. PubMed ID: 9839568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercial identification systems often fail to identify Providencia stuartii.
    Cornaglia G; Dainelli B; Berlutti F; Thaller MC
    J Clin Microbiol; 1988 Feb; 26(2):323-7. PubMed ID: 3277997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region.
    Laupland KB; Parkins MD; Ross T; Pitout JD
    Clin Microbiol Infect; 2007 Jul; 13(7):683-8. PubMed ID: 17403132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-serotyping Providencia alcalifaciens.
    Penner JL; Fleming PC; Whiteley GR; Hennessy JN
    J Clin Microbiol; 1979 Dec; 10(6):761-5. PubMed ID: 521478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providencia rustigianii: a new species in the family Enterobacteriaceae formerly known as Providencia alcalifaciens biogroup 3.
    Hickman-Brenner FW; Farmer JJ; Steigerwalt AG; Brenner DJ
    J Clin Microbiol; 1983 Jun; 17(6):1057-60. PubMed ID: 6874899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in urease activity of endemic hospital strains of Proteus rettgeri and Providencia stuartii.
    Penner JL; Hinton NA; Whiteley GR; Hennessy JN
    J Infect Dis; 1976 Oct; 134(4):370-6. PubMed ID: 789790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative sensitivity to cephaloridine and semisynthetic penicillins of causative agents in purulent infections].
    Fomina IP; Kuznetsova SM; Kalinina TN; Navashin SM
    Antibiotiki; 1972 May; 17(5):436-41. PubMed ID: 4555702
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular characterization of the genera Proteus, Morganella, and Providencia by ribotyping.
    Pignato S; Giammanco GM; Grimont F; Grimont PA; Giammanco G
    J Clin Microbiol; 1999 Sep; 37(9):2840-7. PubMed ID: 10449462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species.
    Barry AL; Hoeprich PD
    Antimicrob Agents Chemother; 1973 Sep; 4(3):354-60. PubMed ID: 4202343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin.
    Bodey GP; Deerhake B
    Appl Microbiol; 1971 Jan; 21(1):61-5. PubMed ID: 4924999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.